Eastman Chemical director granted 408 phantom units
SLAGER DONALD W reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
SLAGER DONALD W reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Donald W. Slager received a compensation grant of 408 Phantom Stock Units. These units were credited under the Directors' Deferred Compensation Plan at no purchase price and each unit tracks the value of one share of common stock.
The award represents an automatic deferral of a portion of the director’s annual cash retainer, with amounts payable only in cash after his service as a director ends. Following this grant, Slager holds a total of 1,699 Phantom Stock Units, including units from prior awards and dividend equivalents reinvested in additional units.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 408 | $0.00 | $0.00 |
Footnotes (3)
- F1. Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
- F2. Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash.
- F3. Includes dividend equivalents reinvested in additional Phantom Stock Units.
Key Figures
Key Terms
Phantom Stock Units financial
Directors' Deferred Compensation Plan financial
dividend equivalents financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did EMN director Donald W. Slager report in this Form 4?
Is the EMN Form 4 transaction an open-market buy or sell of stock?
How many Phantom Stock Units does Donald W. Slager hold after this EMN grant?
What are Phantom Stock Units in the context of Eastman Chemical (EMN)?
How were the 408 Phantom Stock Units for EMN’s director determined?
AI-generated analysis. How Rhea-AI works. Not financial advice.